PMS1 mutation
|
Gastric Cancer
|
PMS1 mutation
|
Gastric Cancer
|
durvalumab Sensitive: C2 – Inclusion Criteria
|
durvalumab Sensitive: C2 – Inclusion Criteria
|
PMS1 mutation
|
Gastric Cancer
|
PMS1 mutation
|
Gastric Cancer
|
CP-675206 Sensitive: C2 – Inclusion Criteria
|
CP-675206 Sensitive: C2 – Inclusion Criteria
|